CAS: 1221-56-3; Sodium,3-[3-(Dimethylaminomethylideneamino)-2,4,6-Triiodophenyl]Propanoate

该化合物是一种化学化合物,主要用作医疗成像中的放射剂,特别是胃肠道X光检查中的放射剂;一种碘酸盐,是一种碘化化合物,通过吸收X光,使图像的对比更加鲜明;该物质具有高碘含量的特点,对于其作为对比介质的有效性至关重要;钠蛋白质通常通过口头或直线方式施用,取决于成像程序;在水中溶解,便于准备和操作;该化合物一般具有良好的耐用性,但与其他碘化对比剂一样,可能会给敏感个人带来过敏反应或不利影响的风险;随着新反光剂的出现,其使用已经减少,但在具体的临床情况下,它仍然是一个相关的选择.与任何制药剂一样,适当的剂量和管理对于确保病人的安全以及成像结果的功效至关重要.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-2022233673-A1
    优先权日:2019-06-04
    标 题:METHODS OF PRODUCING SHIGA TOXIN B-SUBUNIT (STxB) MONOMERS AND OLIGOMERS, AND USES THEREOF
    发明人:BILLET ANNE; SCHMIDT FRÉDÉRIC; JOHANNES LUDGER; SERVENT DENIS; MOURIER GILLES; TARTOUR ÉRIC; KAY MICHAEL; FULCHER JAMES M
    权利人:INST CURIE; CENTRE NAT RECH SCIENT; INST NAT SANTE RECH MED; COMMISSARIAT A LENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES CEA; APHP ASSIST PUBLIQUE HOPITAUX DE PARIS; UNIV PARIS; UNIV OF UTAH RESEARCH FOUDATION; UNIV UTAH RES FOUND
    摘要:A method of producing a monomer of a Shiga toxin B-subunit (STxB) protein or of a variant thereof by peptide chemical synthesis, as well as to a method of producing a pentamer of the STxB protein or of the variant thereof. The methods are particularly advantageous as they overcome major issues typically observed in peptide chemical synthesis, including solubility and purity issues.

    专利号:US-2016138027-A1
    优先权日:2013-03-14
    标 题:Treatment of diseases and conditions associated with dysregulation of mammalian target of rapamycin complex 1 (mtorc1)
    发明人:GAN LIN; MEYER TOBIAS
    权利人:UNIV LELAND STANFORD JUNIOR
    摘要:Compositions and methods for treating diseases and conditions associated with dysregulation of mammalian target of rapamycin complex 1 (mTORC1) are disclosed. The invention is based in part on the discovery that protein mediator of amino acid signaling to mTOR (MORTOR) is involved in amino acid-induced translocation of mTORC1 to lysosomes where MORTOR forms a signaling complex with mTORC1, Ragulator, and Rag GTPases, which controls protein synthesis. In particular, the invention relates to the use of antagonists of MORTOR for treating diseases and conditions associated with dysregulation of mTORC1. Downregulation of expression of MORTOR by RNA interference has been shown to reduce cell proliferation of cancerous cells and may be useful for treating cancer.

    专利号:US-2007148246-A1
    优先权日:2005-08-11
    标题:Nucleic Acid-Based Matrixes
    发明人:LUO DAN; LI YOUGEN
    权利人:LUO DAN; LI YOUGEN
    摘要:Various nucleic acid-based matrixes are provided, comprising nucleic acid monomers as building blocks, as well as nucleic acids encoding proteins, so as to produce novel biomaterials. Methods of utilizing such biomaterials include delivery of biologically active agents, cell and tissue culture, and cell-free protein synthesis.

    专利号:US-2022233727-A1
    优先权日:2019-06-13
    标题:Surface enhanced raman scattering nanoparticles and their use in detecting and imaging oxidative stress
    发明人:THAKOR AVNESH S; RAZAVI MEHDI
    权利人:UNIV LELAND STANFORD JUNIOR
    摘要:Surface enhanced Raman scattering (SERS) nanoparticles and methods of using them for detecting reactive oxygen species are disclosed. In particular, methods of using SERS nanoparticles to detect and quantify reactive oxygen species Synthesis and monitor oxidative stress and disease-relevant changes in levels of reactive oxygen species are provided.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Khimiko-Farmatsevticheskii Zhurnal. Chemical Pharmaceutical Journal. For English translation, see PCJOAU., 14(12)(62), 1980
    摘要:Farmaco, Edizione Pratica., 31(397), 1976 []
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知